According to Hims & Hers Health's latest financial reports the company has $0.19 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.17 B | -27.36% |
2021-12-31 | $0.24 B | 146.76% |
2020-12-31 | $0.10 B | 66% |
2019-12-31 | $60.36 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $10.75 M | -94.43% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.15 B | -21.95% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $0.50 B | 161.94% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $0.94 B | 387.11% | Jersey |